Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 207-221 , April 2008

Androgen biosynthetic pathways in the human prostate

References 

  1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA: A Cancer Journal for Clinicians. 2004;54:8–29
  2. Nesbit RM, Baum WC. Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases. Journal of the American Medical Association. 1950;143:1317–1320
  3. Mettlin C, Natarajan N, Murphy GP. Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American college of Surgeons Commission on Cancer. International Advances in Surgical Oncology. 1982;5:277–321
  4. Labrie F, Belanger A, Kelly PA, et al. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists. Progress in Clinical and Biological Research. 1981;74:273–291
  5. Faure N, Labrie F, Lemay A, et al. Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. Fertility and Sterility. 1982;37:416–424
  6. Wilson JD. Sexual differentiation. Annual Review of Physiology. 1978;40:279–306
  7. Luu-The V, Lachance Y, Labrie C, et al. Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase. Molecular Endocrinology (Baltimore, Md.). 1989;3:1310–1312
  8. Lorence MC, Corbin CJ, Kamimura N, et al. Structural analysis of the gene encoding human 3 beta-hydroxysteroid dehydrogenase/delta 5----4-isomerase. Molecular Endocrinology (Baltimore, Md.). 1990;4:1850–1855
  9. Rhéaume É, Lachance Y, Zhao H-F, et al. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase in human adrenals and gonads. Molecular Endocrinology (Baltimore, Md.). 1991;5:1147–1157
  10. Lachance Y, Luu-The V, Labrie C, et al. Characterization of human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase gene and its expression in mammalian cells. Journal of Biological Chemistry. 1990;265:20469–20475
  11. Lachance Y, Luu-The V, Verreault H, et al. Structure of the human type II 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) gene: adrenal and gonadal specificity. DNA and Cell Biology. 1991;10:701–711
  12. Peltoketo H, Isomaa V, Maentausta O, et al. Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Letters. 1988;239:73–77
  13. Luu The V, Labrie C, Zhao HF, et al. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta. Molecular Endocrinology (Baltimore, Md.). 1989;3:1301–1309
  14. Wu L, Einstein M, Geissler WM, et al. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. The Journal of Biological Chemistry. 1993;268:12964–12969
  15. Geissler WM, Davis DL, Wu L, et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nature Genetics. 1994;7:34–39
  16. Adamski J, Normand T, Leenders F, et al. Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV. The Biochemical Journal. 1995;311:437–443
  17. Dufort I, Rheault P, Huang X-F, et al. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology. 1999;140:568–574
  18. Nokelainen P, Peltoketo H, Vihko R, et al. Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Molecular endocrinology (Baltimore, Md.). 1998;12:1048–1059
  19. Krazeisen A, Breitling R, Imai K, et al. Determination of cDNA, gene structure and chromosomal localization of the novel human 17beta-hydroxysteroid dehydrogenase type 7(1). FEBS Letters. 1999;460:373–379
  20. Fomitcheva J, Baker ME, Anderson E, et al. Characterization of Ke 6, a new 17beta-hydroxysteroid dehydrogenase, and its expression in gonadal tissues. The Journal of Biological Chemistry. 1998;273:22664–22671
  21. Biswas MG, Russell DW. Expression cloning and characterization of oxidative 17beta- and 3alpha-hydroxysteroid dehydrogenases from rat and human prostate. The Journal of Biological Chemistry. 1997;272:15959–15966
  22. Napoli JL. 17beta-Hydroxysteroid dehydrogenase type 9 and other short-chain dehydrogenases/reductases that catalyze retinoid, 17beta- and 3alpha-hydroxysteroid metabolism. Molecular and Cellular Endocrinology. 2001;171:103–109
  23. He XY, Merz G, Mehta P, et al. Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase. The Journal of Biological Chemistry. 1999;274:15014–15019
  24. Li KX, Smith RE, Krozowski ZS. Cloning and expression of a novel tissue specific 17beta-hydroxysteroid dehydrogenase. Endocrine Research. 1998;24:663–667
  25. Luu-The V, Tremblay P, Labrie F. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Molecular Endocrinology (Baltimore, Md.). 2006;20:437–443
  26. Lukacik P, Keller B, Bunkoczi G, et al. Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity. The Biochemical Journal. 2007;402:419–427
  27. Andersson S, Russell DW. Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:3640–3644
  28. Andersson S, Berman DM, Jenkins EP, et al. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature. 1991;354:159–161
  29. Jenkins EP, Hsieh CL, Milatovich A, et al. Characterization and chromosomal mapping of a human steroid 5 alpha- reductase gene and pseudogene and mapping of the mouse homologue. Genomics. 1991;11:1102–1112
  30. Labrie F, Sugimoto Y, Luu-The V, et al. Structure of human type II 5α-reductase gene. Endocrinology. 1992;131:1571–1573
  31. Peterson RE, Imperato-McGinley J, Gautier T, et al. Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency. The American Journal of Medicine. 1977;62:170–191
  32. Imperato-McGinley J, Ip NY, Gautier T, et al. DNA linkage analysis and studies of the androgen receptor gene in a large kindred with complete androgen insensitivity. American Journal of Medical Genetics. 1990;36:104–108
  33. Xu W, Robert C, Thornton PS, et al. Complete androgen insensitivity syndrome due to X chromosome inversion: a clinical report. American Journal of Medical Genetics. Part A. 2003;120:434–436
  34. Fevold HR, Lorence MC, McCarthy JL, et al. Rat P450(17 alpha) from testis: characterization of a full-length cDNA encoding a unique steroid hydroxylase capable of catalyzing both delta 4- and delta 5-steroid-17,20-lyase reactions. Molecular Endocrinology (Baltimore, Md.). 1989;3:968–975
  35. Namiki M, Kitamura M, Buczko E, et al. Rat testis P-450(17)alpha cDNA: the deduced amino acid sequence, expression and secondary structural configuration. Biochemical and Biophysical Research Communications. 1988;157:705–712
  36. Conley AJ, Graham-Lorence SE, Kagimoto M, et al. Nucleotide sequence of a cDNA encoding porcine testis 17 alpha-hydroxylase cytochrome P-450. Biochimica et Biophysica Acta. 1992;1130:75–77
  37. Tremblay Y, Fleury A, Beaudoin C, et al. Molecular cloning and expression of guinea pig cytochrome P450c17 cDNA (steroid 17 alpha-hydroxylase/17,20 lyase): tissue distribution, regulation, and substrate specificity of the expressed enzyme. DNA and Cell Biology. 1994;13:1199–1212
  38. Zuber MX, Simpson ER, Waterman MR. Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science. 1986;234:1258–1261
  39. Lin D, Harikrishna JA, Moore CC, et al. Missense mutation serine106----proline causes 17 alpha-hydroxylase deficiency. The Journal of Biological Chemistry. 1991;266:15992–15998
  40. Brock BJ, Waterman MR. Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry. 1999;38:1598–1606
  41. Perkins LM, Payne AH. Quantification of P450scc, P450(17) alpha, and iron sulfur protein reductase in Leydig cells and adrenals of inbred strains of mice. Endocrinology. 1988;123:2675–2682
  42. Luu-The V, Pelletier G, Labrie F. Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5alpha-reductase, 20alpha-hydroxysteroid dehydrogenase and estrogen sulfotransferase. The Journal of Steroid Biochemistry and Molecular Biology. 2005;93:269–276
  43. Labrie F. Intracrinology. Molecular and Cellular Endocrinology. 1991;78:C113–C118
  44. Labrie F, Belanger A, Cusan L, et al. History of LHRH agonists and combination therapy in prostate cancer. Endocrine-Related Cancer. 1996;3:243–278
  45. Labrie F, Dupont A, Belanger A. Complete androgen blockade for the treatment of prostate cancer. Important Advances in Oncology. 1985;193–217
  46. Labrie F, Luu-The V, Belanger A, et al. Is dehydroepiandrosterone a hormone?. The Journal of Endocrinology. 2005;187:169–196
  47. Rheaume E, Simard J, Morel Y, et al. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nature Genetics. 1992;1:239–245
  48. Andersson S, Geissler WM, Wu L, et al. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. The Journal of Clinical Endocrinology and Metabolism. 1996;81:130–136
  49. Belanger A, Brochu M, Cliche J. Plasma levels of steroid glucuronides in prepubertal, adult and elderly men. Journal of Steroid Biochemistry. 1986;24:1069–1072
  50. Luu-The V, Takahashi M, Labrie F. Purification of microsomal and mitochondrial 3beta-hydroxysteroid dehydrogenase/delta 5- delta 4 isomerase from human placenta. Annals of the New York Academy of Sciences. 1990;595:386–388
  51. Simard J, Ricketts ML, Gingras S, et al. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocrine Reviews. 2005;26:525–582
  52. El-Alfy M, Luu-The V, Huang XF, et al. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology. 1999;140:1481–1491
  53. Sugimoto Y, Lopez-Solache I, Labrie F, et al. Cations inhibit specifically type I 5 alpha-reductase found in human skin. The Journal of Investigative Dermatology. 1995;104:775–778
  54. Jenkins EP, Andersson S, Imperato-McGinley J, et al. Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. The Journal of Clinical Investigation. 1992;89:293–300
  55. Russell DW, Wilson JD. Steroid 5 alpha-reductase: two genes/two enzymes. Annual Review of Biochemistry. 1994;63:25–61
  56. Bayne CW, Donnelly F, Chapman K, et al. A novel coculture model for benign prostatic hyperplasia expressing both isoforms of 5 alpha-reductase. The Journal of Clinical Endocrinology and Metabolism. 1998;83:206–213
  57. Chang SM, Chung LW. Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology. 1989;125:2719–2727
  58. Delos S, Carsol JL, Ghazarossian E, et al. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. The Journal of Steroid Biochemistry and Molecular Biology. 1995;55:375–383
  59. Delos S, Iehle C, Martin PM, et al. Inhibition of the activity of ‘basic’ 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells. The Journal of Steroid Biochemistry and Molecular Biology. 1994;48:347–352
  60. Lazier CB, Thomas LN, Douglas RC, et al. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. The Prostate. 2004;58:130–144
  61. Thigpen AE, Silver RI, Guileyardo JM, et al. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. The Journal of Clinical Investigation. 1993;92:903–910
  62. Silver RI, Wiley EL, Davis DL, et al. Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease. The Journal of Urology. 1994;152:433–437
  63. Pelletier G, Luu-The V, Huang XF, et al. Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin. The Journal of Urology. 1998;160:577–582
  64. Zhongyi S, Rantakari P, Lamminen T, et al. Transgenic male mice expressing human hydroxysteroid dehydrogenase 2 indicate a role for the enzyme independent of its action on sex steroids. Endocrinology. 2007;148:3827–3836
  65. van Grunsven EG, van Berkel E, Ijlst L, et al. Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:2128–2133
  66. Huyghe S, Mannaerts GP, Baes M, et al. Peroxisomal multifunctional protein-2: the enzyme, the patients and the knockout mouse model. Biochimica et Biophysica Acta. 2006;1761:973–994
  67. Perez-Cerda C, Garcia-Villoria J, Ofman R, et al. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease. Pediatric Research. 2005;58:488–491
  68. Mindnich R, Moller G, Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology. 2004;218:7–20
  69. Robert A, Rheault P, Labrie F, et al. Identification and characterization of an estrogen-activating and androgen-inactivating (EHAL) enzyme. In: Breast Cancer Research National Scientific Conference, Reasons for Hope Abstract: 82; 1999.
  70. Robert A, Luu-The V. Cloning and characterization of a new form of human 3-keto-reductase specific for saturated steroid. In: CDA/CSEM Professional Conference and Annual Meetings, Ottawa; 1999.
  71. Torn S, Nokelainen P, Kurkela R, et al. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochemical and Biophysical Research Communications. 2003;305:37–45
  72. Marijanovic Z, Laubner D, Moller G, et al. Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Molecular Endocrinology (Baltimore, Md.). 2003;17:1715–1725
  73. Luu-The V. Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenases. Journal of Steroid Biochemistry and Molecular Biology. 2001;76:143–151
  74. Pelletier G, Luu-The V, Li S, et al. Localization of type 8 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization. The Journal of Histochemistry and Cytochemistry. 2005;53:1257–1271
  75. Liu S, Huang C, Li D, et al. Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9. Acta Biochimica Polonica. 2007;54:213–218
  76. Karavolas HJ, Baedecker ML, Engel LL. Human placental 17 beta-estradiol dehydrogenase. V. Purification and partial characterization of the diphosphopyridine nucleotide (triphosphopyridine nucleotide)-linked enzyme. The Journal of Biological Chemistry. 1970;245:4948–4952
  77. Luu-The V, Labrie C, Zhao HF, et al. Purification, cloning, complementary DNA structure, and predicted amino acid sequence of human estradiol 17 beta-dehydrogenase. Annals of the New York Academy of Sciences. 1990;595:40–52
  78. Pittaway DE, Andersen RN, Givens JR. Characterization of human ovarian oestradiol-17 beta oxidoreductase activity. Acta Endocrinologica. 1977;85:624–635
  79. Mendonca BB, Arnhold IJ, Bloise W, et al. 17Beta-hydroxysteroid dehydrogenase 3 deficiency in women. The Journal of Clinical Endocrinology and Metabolism. 1999;84:802–804
  80. Pelletier G, Luu-The V, Tetu B, et al. Immunocytochemical localization of type 5 17beta-hydroxysteroid dehydrogenase in human reproductive tissues. The Journal of Histochemistry and Cytochemistry. 1999;47:731–738
  81. Luu-The V, Dufort I, Pelletier G, et al. Type 5 17β-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Molecular and Cellular Endocrinology. 2001;77–82
  82. Liu H, Zheng S, Bellemare V, et al. Expression and localization of estrogenic type 12 17beta-hydroxysteroid dehydrogenase in the cynomolgus monkey. BMC Biochemistry. 2007;8:2
  83. Blanchard PG, Luu-The V. Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17beta-hydroxysteroid dehydrogenase. The Journal of Endocrinology. 2007;194:449–455
  84. Hastings CD, Djoseland O. Androgen metabolism by rat epididymis: metabolic conversion of 3H-dihydrotestosterone in vivo and in vitro. Archives of Andrology. 1979;2:215–222
  85. Taurog JD, Moore RJ, Wilson JD. Partial characterization of the cytosol 3 alpha-hydroxysteroid: NAD(P)+oxidoreductase of rat ventral prostate. Biochemistry. 1975;14:810–817
  86. Penning TM, Sharp RB, Krieger NR. Purification and properties of 3 alpha-hydroxysteroid dehydrogenase from rat brain cytosol. Inhibition by nonsteroidal anti-inflammatory drugs and progestins. The Journal of Biological Chemistry. 1985;260:15266–15272
  87. Djoseland O, Hastings CD, Hansson V. Androgen metabolism by rat epididymis. 5. Metabolic conversion and nuclear binding after injection of 5alpha-androstane-3alpha, 17beta-diol, in vivo. Steroids. 1976;28:585–596
  88. Winters CJ, Molowa DT, Guzelian PS. Isolation and characterization of cloned cDNAs encoding human liver chlordecone reductase. Biochemistry. 1990;29:1080–1087
  89. Khanna M, Qin KN, Wang RW, et al. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases. The Journal of Biological Chemistry. 1995;270:20162–20168
  90. Dufort I, Soucy P, Labrie F, et al. Molecular cloning of human type 3 3 alpha-hydroxysteroid dehydrogenase that differs from 20 alpha-hydroxysteroid dehydrogenase by seven amino acids. Biochemical and Biophysical Research Communications. 1996;228:474–479
  91. Dufort I, Labrie F, Luu-The V. Human types 1 and 3 3alpha-hydroxysteroid dehydrogenases: differential lability and tissue distribution. Journal of Clinical Endocrinology and Metabolism. 2001;86:841–846
  92. Lin HK, Penning TM. Cloning, sequencing, and functional analysis of the 5′-flanking region of the rat 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase gene. Cancer Research. 1995;55:4105–4113
  93. Jez JM, Flynn TG, Penning TM. A new nomenclature for the aldo-keto reductase superfamily. Biochemical Pharmacology. 1997;54:639–647
  94. Rheault P, Charbonneau A, Luu-The V. Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). Biochimica et Biophysica Acta. 1999;1447:17–24
  95. Wilson JD, Leihy MW, Shaw G, et al. Androgen physiology: unsolved problems at the millennium. Molecular and Cellular Endocrinology. 2002;198:1–5
  96. Wilson JD, Auchus RJ, Leihy MW, et al. 5alpha-androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate. Endocrinology. 2003;144:575–580
  97. Huang XF, Luu-The V. Modulation of the androgenic response by recombinant human 11-cis retinol dehydrogenase. The Journal of Steroid Biochemistry and Molecular Biology. 2001;77:129–133
  98. Mahendroo M, Wilson JD, Richardson JA, et al. Steroid 5alpha-reductase 1 promotes 5alpha-androstane-3alpha,17beta-diol synthesis in immature mouse testes by two pathways. Molecular and Cellular Endocrinology. 2004;222:113–120
  99. Eckstein B, Borut A, Cohen S. Metabolic pathways for androstanediol formation in immature rat testis microsomes. Biochimica et Biophysica Acta. 1987;924:1–6
  100. Zhou DJ, Pompon D, Chen SA. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg. Proceedings of the National Academy of Sciences of the United States of America. 1991;88:410–414

PII: S1521-690X(08)00009-2

doi: 10.1016/j.beem.2008.01.008

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 207-221 , April 2008

Article Tools

* Image Usage & Resolution